pyrazolanthrone has been researched along with valine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ellis, S; Fricker, M; Hunt, P; Lograsso, P; Pollack, SJ; Wilkie, N | 1 |
Das, HK; Mueller, B; Tchedre, K | 1 |
2 other study(ies) available for pyrazolanthrone and valine
Article | Year |
---|---|
Substituting c-Jun N-terminal kinase-3 (JNK3) ATP-binding site amino acid residues with their p38 counterparts affects binding of JNK- and p38-selective inhibitors.
Topics: Adenosine Triphosphate; Alanine; Amino Acids; Animals; Anthracenes; Binding Sites; Biotinylation; Crystallography, X-Ray; Enzyme Inhibitors; Fluorescence Resonance Energy Transfer; Glutathione; Humans; Imidazoles; Inhibitory Concentration 50; Isoleucine; Kinetics; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 10; Models, Biological; Models, Chemical; Models, Molecular; Mutation; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Point Mutation; Protein Binding; Protein Folding; Pyrimidines; Valine | 2005 |
Repression of transcription of presenilin-1 inhibits γ-secretase independent ER Ca²⁺ leak that is impaired by FAD mutations.
Topics: Amyloid Precursor Protein Secretases; Anthracenes; Calcium; Carrier Proteins; Cell Line, Tumor; Cytosol; DNA Helicases; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Inositol 1,4,5-Trisphosphate Receptors; Methionine; Mi-2 Nucleosome Remodeling and Deacetylase Complex; Mutation; Neuroblastoma; Nuclear Proteins; Peptide Fragments; Presenilin-1; Signal Transduction; Statistics, Nonparametric; Thapsigargin; Transfection; Valine | 2012 |